Q4 Highlights New advanced X-ray product Altumira™ Plus with scatter correction released Participation in world’s largest medical imaging conference, Radiological Society of North America (RSNA) Increasing interest from customers and OEMs in our products Strategic investments in Point of Care…
ContextVision offers solutions for ultrasound, X-ray and MRI. With a core business focus on image enhancement software designed to deliver unprecedented image quality, ContextVision is the global market leader and partner to leading OEMs, with solutions installed worldwide in more…
Taking AI and machine learning to whole new fields When it comes to applying artificial intelligence (AI) and machine learning to medical imaging, ContextVision has always been ahead of its field. Over the last decades, the company’s pioneering technologies have…
STOCKHOLM – October 26, 2023. In Q3, ContextVision achieved an unprecedented high in net sales, totaling SEK 32.8M (25.6), which adds yet another record-breaking quarter. Additionally, net sales for the first nine months also reached a new record at SEK…
Tranche 1 Dividend amount: SEK 0.15 per share Declared currency: SEK Last day including right: 5 May 2023 Ex-date: 8 May 2023 *Correction: Record date: 9 May 2023 Payment date: on or about 16 May 2023 Date of approval: 3…
On May 3rd 2023, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. The company’s robust growth in 2022 and the successful spin off of Inify Laboratories AB has resulted in a strong balance sheet. In the light of…
STOCKHOLM – April 27th, 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today proudly presents their Q1 Report for 2023. The robust growth continues and in the first quarter of 2023 the company saw…
STOCKHOLM – March 30, 2023 – ContextVision hereby invites shareholders to the Annual General Meeting on May 3, 2023. Please find attached the invitation including agenda and details on how to register and vote. Please contact: finance@contextvision.se for any questions regarding the AGM.…
STOCKHOLM – Feb 16, 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today reports its fourth quarter results. Net sales record The company delivers another record quarter with a net sales of SEK…
STOCKHOLM – November 02 2022 – Gerald Pötzsch, CEO of ContextVision, has during the period of August 31st until November 1st, 2022 purchased 10.000 shares in ContextVision AB at an average price of NOK 8,71 per share. After the transaction, Mr Pötzsch holds a total of 15.000 shares in…